Below are the most recent publications written about "Government Regulation" by people in Profiles.
-
DeMartino ES, Sperry BP, Doyle CK, Chor J, Kramer DB, Dudzinski DM, Mueller PS. US State Regulation of Decisions for Pregnant Women Without Decisional Capacity. JAMA. 2019 04 23; 321(16):1629-1631.
-
Capalbo A, Chokoshvili D, Dugoff L, Franasiak J, Gleicher N, Pennings G, Simon C. Should the reproductive risk of a couple aiming to conceive be tested in the contemporary clinical context? Fertil Steril. 2019 02; 111(2):229-238.
-
Neubert H, Song A, Lee A, Wei C, Duggan J, Xu K, Woolf E, Evans C, Palandra J, Laterza O, Amur S, Berger I, Bustard M, Cancilla M, Chen SC, Cho SJ, Ciccimaro E, Cludts I, Cocea L, D'Arienzo C, Danan-Leon L, Donato LD, Garofolo F, Haidar S, Ishii-Watabe A, Jiang H, Kadavil J, Kassim S, Kurki P, Blaye OL, Liu K, Mathews R, Lima Santos GM, Niwa M, Pedras-Vasconcelos J, Qian M, Rago B, Saad O, Saito Y, Savoie N, Su D, Szapacs M, Tampal N, Vinter S, Wang J, Welink J, Whale E, Wilson A, Xue YJ. 2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs). Bioanalysis. 2017 Dec; 9(23):1895-1912.
-
Hume M, Lewis LL, Nelson RM. Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies. J Med Ethics. 2017 12; 43(12):857-860.
-
Lu A, Scott KS, Chan-Hosokawa A, Logan BK. Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem. J Anal Toxicol. 2017 Mar 01; 41(2):134-139.
-
Hollin IL, Hanson C, Bridges JFP, Peay H. Developing a Patient-Centered Benefit-Risk Survey: A Community-Engaged Process. Value Health. 2016 Sep - Oct; 19(6):751-757.
-
Stegall MD, Stock PG, Andreoni K, Friedewald JJ, Leichtman AB. Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation system. Hum Immunol. 2017 Jan; 78(1):4-8.
-
Adler JT, Axelrod DA. Regulations' Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered? AMA J Ethics. 2016 Feb 01; 18(2):133-42.
-
Zachariah P, Reagan J, Furuya EY, Dick A, Liu H, Herzig CT, Pogorzelska-Maziarz M, Stone PW, Saiman L. The association of state legal mandates for data submission of central line-associated bloodstream infections in neonatal intensive care units with process and outcome measures. Infect Control Hosp Epidemiol. 2014 Sep; 35(9):1133-9.
-
Choo EK, Benz M, Zaller N, Warren O, Rising KL, McConnell KJ. The impact of state medical marijuana legislation on adolescent marijuana use. J Adolesc Health. 2014 Aug; 55(2):160-6.